Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Serelaxin reduces occurrence of in-hospital worsening heart failure

Serelaxin reduces the occurrence of in-hospital worsening heart failure by almost half in patients admitted for acute heart failure, according to the RELAX-AHF trial. The results were presented for the first time today at ESC Congress by co-principal investigator Professor John R. Teerlink.

1 Sep 2014

'Good' cholesterol turns 'bad' by sugar-derived substance

Scientists at the University of Warwick have discovered that 'good' cholesterol is turned 'bad' by a sugar-derived substance.

1 Sep 2014

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry.

1 Sep 2014

Local anaesthetic is safe, effective for transcatheter aortic valve implantation

Local anaesthetic is as safe and effective for transcatheter aortic valve implantation (TAVI) as general anaesthetic, according to results of the FRANCE 2 registry presented at ESC Congress today by Dr Romain Chopard from France.

1 Sep 2014

Stereotactic radiosurgery feasible for multiple brain metastases

Stereotactic radiosurgery is a feasible treatment option for cancer patients with up to 10 brain metastases, Japanese researchers report in The Lancet Oncology.

28 Aug 2014

Lifestyle intervention shows kidney benefits in diabetic patients

A lifestyle intervention focused on weight loss and increasing physical activity should be considered as additional treatment to prevent advanced kidney disease in overweight or obese people with Type 2 diabetes, say researchers.

28 Aug 2014

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

26 Aug 2014

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs.

26 Aug 2014

ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica is participating in innovative research into the development of a safe, non-invasive treatment for BPH or enlarged prostate. BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems.

23 Aug 2014

Calcium buildup in coronary arteries of chronic kidney disease patients indicates heart disease risk

Calcium buildup in the coronary arteries of chronic kidney disease patients may be a strong indicator of heart disease risk, according to a new study in the Journal of the American Society of Nephrology (JASN).

22 Aug 2014

Study links gum disease to lung disease, cancer and heart failure

Most people are very familiar with the reality that, if they don't practice regular brushing and overall good dental hygiene, they are at risk for developing gum disease. Less well known is the full extent of the potential harm caused by gum disease.

22 Aug 2014

Death rate increases with hospitals shift from inpatient procedures to outpatient for urological surgeries

As hospitals have shifted an array of common urological surgeries from inpatient procedures to outpatient, potentially preventable deaths have increased following complications.

20 Aug 2014

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Amgen (NASDAQ: AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Meta-analysis shows blood pressure variability and mortality link

A systematic review and meta-analysis of studies investigating the link between visit-to-visit variability of blood pressure and cardiovascular disease or all-cause mortality has revealed a modest, but significant, association.

18 Aug 2014

DaVita HealthCare Partners recognized as Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners Inc., a leading provider of kidney care and health care services, today announced it has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the third consecutive year the publication has recognized the company's commitment to teammate health and wellness with a first place rank in the Healthiest Employer award program.

18 Aug 2014

Nutrition counseling by registered dietitian nutritionist can help prevent or delay diabetes

A new study, indicating that Americans have approximately a 40 percent risk of developing diabetes during their lifetime, offers more evidence that nutrition counseling provided by a registered dietitian nutritionist can help prevent or delay diabetes and its related health problems through lifestyle and dietary changes, according to the Academy of Nutrition and Dietetics.

16 Aug 2014

Nephrology News and Research

Further Reading

Serelaxin reduces occurrence of in-hospital worsening heart failure

'Good' cholesterol turns 'bad' by sugar-derived substance

Morbidity, mortality of AF patients remains high at 1 year even with good use of oral anticoagulants

Local anaesthetic is safe, effective for transcatheter aortic valve implantation

Stereotactic radiosurgery feasible for multiple brain metastases

Lifestyle intervention shows kidney benefits in diabetic patients

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

ProMedica participates in innovative research into development of non-invasive treatment for BPH

Calcium buildup in coronary arteries of chronic kidney disease patients indicates heart disease risk

Study links gum disease to lung disease, cancer and heart failure

Death rate increases with hospitals shift from inpatient procedures to outpatient for urological surgeries

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Meta-analysis shows blood pressure variability and mortality link

DaVita HealthCare Partners recognized as Metro Denver's healthiest extra-large employer

Nutrition counseling by registered dietitian nutritionist can help prevent or delay diabetes

Cases of Ebola virus in West Africa continue to rise

HDAC inhibitors may also be effective against kidney stones

Overweight and obesity linked to 10 common cancers and over 12 000 cases every year in the UK

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News